FDA Investigator Frederick L Fricke
Frederick L Fricke has conducted inspections on 10 sites in 2 countries as of 26 Feb 2002. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
10
Last Inspection Date:
26 Feb 2002
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Puerto Rico,
United States of America
FDA Investigators that have inspected at least one site in common with Frederick L Fricke:
Adalberto Cajigas,
Adam R Cooke,
Alan P Kurtzberg,
Alicia M Mozzachio,
Alyson C Tanner,
Amanda L Fyles,
Amir Alavi,
Andrew S Limson,
Arie C Menachem,
Arlene M Badillo,
Bichsa T Tran,
Binh T Nguyen,
Brenda S Zimmer, PhD,
Bryan A Galvez,
Calvin B Koerner,
Carla J Lundi,
Carlos A Medina,
Carrie A Hughes,
Caryn M Everly,
Caryn M Mcnab,
Cassandra L Abellard,
Cathleen A Carr Sharpe,
CDR Ileana Barreto Pettit,
Colleen F Hoyt,
Comyar Shoghi,
Cynthia J Lee, MS,
Cynthia Jim, CSO,
Dejon N Harris,
Diane Cvan Leeuwen,
Dr. Carmelo Rosa,
Dr. Chunchang Fang,
Dusty F Snoeberg,
Dyana K Stone,
Erika V Butler,
Frank L Cordova,
Fred L Fricke,
Geraldine D Sanders,
Ginger M Sykes,
Gregory A Berg,
Haroon Vohra (NMI),
Isabel Y Espinosa,
Ivis L Negron,
Jamie L Dion,
Janet D Blount,
Jeffery A Johnson,
Jennifer M Gogley,
Jennifer M Menendez,
Joe X Phillips,
Joey V Quitania,
John A Gonzalez,
Jorge L Guadalupe,
Jorge L Lajara,
Jose A Lopez,
Jose A Moreno,
José E Meléndez,
Jose R Lopez,
Jose Velez,
Joseph X Phillips,
Juan Rjimenez Garcia,
Karen A Wolnik,
Karen Wolnik,
Kari M Johansen,
Katherine E Jacobitz,
Katherine Szestypalow,
Kent C Faul,
Kham Phommachanh,
Kim Lthomas Cruse,
Kimberley A Hoefen,
Lakecha N Lewis,
Libia M Lugo,
Liming Zhang,
Linda F Murphy,
Linda M Cheny,
Linda Thai,
Lisa M Lopez,
Lourdes Andujar,
Marco S Esteves,
Marcus F Yambot,
Margarita Santiago,
Marianela Aponte Cruz,
Maribel V Juarbe,
Marie Falcone,
Marie T Falcone,
Mariza M Jafary,
Marta E Gonzalez,
Matthew R Dionne,
Merril E Racke,
Merril Racke, PhD,
Michael A Charles,
Michael D Garcia,
Michael J Kuchta,
Michael Kuchta,
Michael R Goga,
Miguel A Martinez Perez,
Miguel Hernandez Sanchez,
Mihaly S Ligmond,
Myriam M Sosa,
Nathan M Jornod,
Nayan J Patel,
Noreen Muñiz,
Omotunde O Osunsanmi,
Patricia A Brown,
Patricia A Cortez,
Patricia Brown,
Peter C Chow,
Prabhu P Raju,
Rafael Nevarez Nieves,
Rakhi B Shah,
Ramon A Hernandez,
Raymond T Oji,
Rebecca H Lee,
Rebecca Parrilla,
Rebecca Rodriguez,
Robert Sharpnack,
Roy R Rinc,
Ryan J Borges,
Saied A Asbagh,
Sandra S Saniga,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Sean P Desbrow,
Shannon B Ruelle,
Sonia M Monges,
Sparky L Bartee,
Steven B Barber,
Steven E Porter, Jr,
Sue Lee Chan,
Tenzin Jangchup,
Terri L Dodds,
Thai T Duong,
Thanh M Andrews,
Thao T Kwan,
Theressa B Smith,
Thomas J Arista,
Thomas R Beilke,
Tony J Wu,
Tracey T Duong,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Valerie L Whipp,
Vashti E Bocker,
Virgilio F Pacio, CSO,
Walden H Lee,
William J Leonard,
Yasamin Ameri,
Yumi J Hiramine,
Zachary L Miller,
Zachary L Stamm
Frederick L Fricke's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2000 | EIR | Watson Laboratories, Inc. - EIR, 2000-09-14 |
| September, 2000 | EIR | Teva Parenteral Medicines, Inc. - EIR, 2000-09-18 |
| August, 2000 | FDA 483 | Watson Laboratories, Inc. - Form 483, 2000-08-17 |
| August, 2001 | EIR | Sandoz Incorporated - EIR, 2001-08-24 |
| August, 2000 | EIR | Watson Laboratories, Inc.-(Actavis) - Florida - EIR, 2000-08-22 |
| August, 2000 | FDA 483 Response | Watson Laboratories, Inc. - Form 483R, 2000-09-20 |
| February, 2002 | EIR | Bristol-Myers Squibb Manufacturing Company Unlimited Company - EIR, 2002-02-28 |
| August, 2000 | EIR | Watson Laboratories, Inc. - EIR, 2000-08-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more